<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="∗∗Corresponding author. zbeixian@126.com ∗∗∗Corresponding author at: State Key Laboratory of" exact="Respiratory" post="Diseases, Guangzhou Institute of Respiratory Health, National Clinical Centre"/>
 <result pre="at: State Key Laboratory of Respiratory Diseases, Guangzhou Institute of" exact="Respiratory" post="Health, National Clinical Centre of Respiratory Disease, the First"/>
 <result pre="Diseases, Guangzhou Institute of Respiratory Health, National Clinical Centre of" exact="Respiratory" post="Disease, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou,"/>
 <result pre="and subsequently its underlying mechanism against influenza A virus (IAV)" exact="infection" post="was investigated in vitro and in vivo. Our results"/>
 <result pre="exhibited broad-spectrum antiviral activity against IAV resulting from reduction of" exact="viral" post="polymerase transcription activity. Erucic acid was found to exert"/>
 <result pre="acid was found to exert inhibitory effects on IAV or" exact="viral" post="(v) RNA-induced pro-inflammatory mediators as well as interferons (IFNs)."/>
 <result pre="in IFN-β-sensitized cells. Additionally, IAV- or vRNA-triggered apoptosis of alveolar" exact="epithelial" post="A549 cells was prevented by erucic acid. In vivo, erucic"/>
 <result pre="acid. In vivo, erucic acid administration consistently displayed decreased lung" exact="viral" post="load and viral antigens expression. Meanwhile, erucic acid markedly"/>
 <result pre="erucic acid administration consistently displayed decreased lung viral load and" exact="viral" post="antigens expression. Meanwhile, erucic acid markedly reduced CD8+ cytotoxic"/>
 <result pre="p38 MAPK Lung injury 1 Introduction Influenza A virus (IAV)" exact="infection" post="is a major cause of acute respiratory tract diseases"/>
 <result pre="Influenza A virus (IAV) infection is a major cause of" exact="acute" post="respiratory tract diseases and is associated with respiratory syndromes"/>
 <result pre="A virus (IAV) infection is a major cause of acute" exact="respiratory" post="tract diseases and is associated with respiratory syndromes ranging"/>
 <result pre="cause of acute respiratory tract diseases and is associated with" exact="respiratory" post="syndromes ranging from mild to life-threatening conditions, which constitutes"/>
 <result pre="date, the expanding understanding of the pathogenesis of influenza virus" exact="infections" post="provided direction for the development of effective therapeutic strategies."/>
 <result pre="direction for the development of effective therapeutic strategies. Analysis of" exact="viral" post="components using reverse genetics methods has elucidated their function"/>
 <result pre="inflammation and host cell death [5,6], which contribute to enhanced" exact="disease" post="severity. Moreover, early antiviral therapy provides better therapeutic benefits"/>
 <result pre="benefits but is ineffective in critically ill patients with influenza" exact="virus infection" post="[7]. Excessive inflammation triggered by viruses is another aspect"/>
 <result pre="but is ineffective in critically ill patients with influenza virus" exact="infection" post="[7]. Excessive inflammation triggered by viruses is another aspect"/>
 <result pre="factors that serve a critical role in determining outcomes of" exact="viral infection." post="A significant correlation between the severity of clinical signs"/>
 <result pre="was found in humans and ferrets with seasonal influenza virus" exact="infections" post="[8,9]. Intense pro-inflammatory responses were observed in fatal cases"/>
 <result pre="responses were observed in fatal cases of high pathogenic H5N1" exact="virus infection" post="[10]. However, it is evident that mice deficient in"/>
 <result pre="were observed in fatal cases of high pathogenic H5N1 virus" exact="infection" post="[10]. However, it is evident that mice deficient in"/>
 <result pre="not provided a survival benefit compared with untreated mice after" exact="viral" post="challenge [11]. A reasonable explanation for this paradox seems"/>
 <result pre="reasonable explanation for this paradox seems to be that both" exact="viral" post="factors and the host immune response are important contributors"/>
 <result pre="limit virus spread. Therefore, the inhibition of signaling required for" exact="viral" post="replication exerts antiviral effects and attenuates virus-mediated excessive pro-inflammatory"/>
 <result pre="viruses. Cell lines with decreased NF-κB activities result in decreased" exact="susceptibility to" post="influenza virus propagation [14]. Several studies revealed that influenza"/>
 <result pre="studies revealed that influenza virus affects NF-κB signaling to reduce" exact="viral" post="(v) RNA synthesis and viral ribonucleoprotein complex (vRNP) nuclear"/>
 <result pre="affects NF-κB signaling to reduce viral (v) RNA synthesis and" exact="viral" post="ribonucleoprotein complex (vRNP) nuclear export, and thereby virus production"/>
 <result pre="NF-κB-mediated immune responses, inhibition of NF-κB activation or its genetic" exact="deficiency" post="suppresses influenza virus-mediated robust production of inflammatory mediators, such"/>
 <result pre="Strikingly, administration of NF-κB inhibitors protects mice against lethal influenza" exact="virus infection" post="[18]. Additionally, activation of p38 kinase, a signaling mediator"/>
 <result pre="administration of NF-κB inhibitors protects mice against lethal influenza virus" exact="infection" post="[18]. Additionally, activation of p38 kinase, a signaling mediator"/>
 <result pre="intra- and extracellular stimuli and governs various biological processes, supports" exact="viral" post="replication and associates with virus-associated dysregulation of inflammatory response."/>
 <result pre="studies suggested that dysregulation of pro-inflammatory cytokine expression in HPAIV-infected" exact="primary" post="human macrophages and bronchial epithelial cells is correlated with"/>
 <result pre="pro-inflammatory cytokine expression in HPAIV-infected primary human macrophages and bronchial" exact="epithelial" post="cells is correlated with hyperactivation of p38 kinase [21,22]."/>
 <result pre="against lethal challenges with H5N1 virus, accompanied by markedly reduced" exact="viral" post="titers and levels of dysregulated cytokines [23]. The severity"/>
 <result pre="levels of dysregulated cytokines [23]. The severity of seasonal influenza" exact="virus infection" post="in patients is associated with p38 kinase-mediated hypercytokinemia in"/>
 <result pre="of dysregulated cytokines [23]. The severity of seasonal influenza virus" exact="infection" post="in patients is associated with p38 kinase-mediated hypercytokinemia in"/>
 <result pre="targeting the NF-κB signaling pathway and p38 kinase can limit" exact="viral" post="replication and excessive pro-inflammatory responses, and may be promising"/>
 <result pre="be of interest in the development of drugs for influenza" exact="disease" post="intervention. Among these active components, the monounsaturated fatty acid"/>
 <result pre="virus-mediated pro-inflammatory responses was investigated. 2 Materials and methods 2.1" exact="General" post="experimental procedures NMR spectra were recorded on a Bruker-400"/>
 <result pre="Cell lines and viruses Human embryonic kidney cells (293) and" exact="lung adenocarcinoma" post="cells (A549) were purchased from the ATCC and maintained"/>
 <result pre="lines and viruses Human embryonic kidney cells (293) and lung" exact="adenocarcinoma" post="cells (A549) were purchased from the ATCC and maintained"/>
 <result pre="maintained in Dulbecco’s modified Eagle’s medium (DMEM)/F12 (1:1) (Gibco; Thermo" exact="Fisher" post="Scientific, Inc., Waltham, MA, USA) while Madin-Darby canine kidney"/>
 <result pre="obtained from the ATCC and maintained in DMEM (Gibco; Thermo" exact="Fisher" post="Scientific, Inc.,); all media were supplemented with 10% fetal"/>
 <result pre="were supplemented with 10% fetal bovine serum (FBS; Gibco; Thermo" exact="Fisher" post="Scientific, Inc.,). Influenza virus A/PR/8/34 (H1N1), A/GZ/GIRD07/09 (H1N1), A/HK/8/68"/>
 <result pre="cells were inoculated with 100-fold of the 50% tissue culture" exact="infectious" post="dose (100 × TCID50) of the influenza virus strains including A/PR/8/34"/>
 <result pre="A/HK/Y280/97 (H9N2), A/Duck/Guangdong/1994 (H7N3) for 2 h at 37 °C. Subsequently, the" exact="viral" post="inoculum was discarded and replaced with diluted compounds including"/>
 <result pre="indicated concentration of compounds or DMSO. The culture supernatant containing" exact="viral" post="particles was collected at 24 h post infection (p.i.) and"/>
 <result pre="culture supernatant containing viral particles was collected at 24 h post" exact="infection" post="(p.i.) and stored at −80 °C. Then, MDCK cells were"/>
 <result pre="covered with DMEM containing 0.8% agarose in the presence or" exact="absence of" post="the compounds. Plates were inverted and incubated at 37 °C"/>
 <result pre="in the presence or absence of the compounds. Plates were" exact="inverted" post="and incubated at 37 °C for 3 days. Cells were"/>
 <result pre="and stained with 0.1% crystal violet for visualization of the" exact="viral" post="plaques. 2.6 Animal experiments All animal experiments were approved"/>
 <result pre="Use of Laboratory Animals of the National Institutes of Health." exact="Female" post="BALB/c mice (age, 4–6 weeks; weight, 18–20 g) were obtained"/>
 <result pre="specific pathogen-free conditions at the Guangzhou State Key Laboratory of" exact="Respiratory" post="Diseases. Mice were randomly divided into five groups: Control"/>
 <result pre="or 100 mg/kg/day for 7 days) at 2 days prior to" exact="viral infection;" post="oseltamivir phosphate treatment group, intragastric administration of oseltamivir phosphate"/>
 <result pre="phosphate (60 mg/kg/d, for 7 days) at 2 days prior to" exact="viral" post="challenge. For viral infection, mice were anesthetized by inhalation"/>
 <result pre="7 days) at 2 days prior to viral challenge. For" exact="viral infection," post="mice were anesthetized by inhalation of 5% isoflurane and"/>
 <result pre="overnight at 4 °C, followed by incubation with horseradish peroxidase (HRP)-conjugated" exact="secondary" post="antibody (1:200; Multi-Sciences). Sections were developed with DAB reagent"/>
 <result pre="China) and counterstained with hematoxylin. 2.8 Antibodies and Western blotting" exact="Primary" post="antibodies against P65, phosphorylated (P)–P65, P38, P–P38, ERK1/2, P-ERK1/2,"/>
 <result pre="antibody against CD3 was obtained from Abcam. Horseradish peroxidase (HRP)-labeled" exact="secondary" post="antibodies were from Multi-Sciences. Human recombinant TNF-α and IFN-β"/>
 <result pre="from Multi-Sciences. Human recombinant TNF-α and IFN-β were from PeproTech." exact="Total" post="protein extracts from lung tissues or cells were prepared"/>
 <result pre="4 °C and aliquots of the supernatant were stored at −80 °C." exact="Protein" post="concentrations were determined with a BCA protein assay kit"/>
 <result pre="membranes and immunoblotted with indicated antibodies. After incubation with HRP-labeled" exact="secondary" post="antibody, signals were developed using an ECL detection system"/>
 <result pre="using Lipofectamine 2000 (Invitrogen) in 6-well plates for 24 h. 2.12" exact="Transient" post="transfection and luciferase assay The effect of erucic acid"/>
 <result pre="transfection and luciferase assay The effect of erucic acid on" exact="viral" post="minigenome reporter systems was assessed as described previously [33]."/>
 <result pre="influenza virus (MOI = 0.1) or IFN-β (500 ng/mL) in the presence or" exact="absence of" post="erucic acid for 24 h. For NF-κB activity assays, 293 cells"/>
 <result pre="were infected with influenza virus (MOI = 0.1) in the presence or" exact="absence of" post="erucic acid for 24 h. Cells were lysed for luciferase"/>
 <result pre="the maximum dose for investigating the mechanism of action against" exact="virus infection." post="Fig. 1 Chemical structure and cytotoxicity of erucic acid."/>
 <result pre="of erucic acid was attributed to its inhibitory effect on" exact="viral" post="HA and NA. Interestingly, the data suggested that erucic"/>
 <result pre="the data suggested that erucic acid did not interfere with" exact="viral" post="HA and NA activities (data not shown). Furthermore, we"/>
 <result pre="minigenome assays for determining the transcription activity driven by the" exact="viral" post="polymerase in the presence of erucic acid. Erucic acid"/>
 <result pre="that erucic acid exerted anti-influenza virus efficacy via inhibition of" exact="viral" post="polymerase transcription activity. Table 1 Antiviral activity of erucic"/>
 <result pre="0.1) and incubated for 24 h in the presence or" exact="absence of" post="erucic acid. Culture supernatants were collected and progeny virus"/>
 <result pre="∗∗∗P &amp;lt; 0.001 vs. non-treated group. (C) Erucic acid reduced" exact="viral" post="polymerase activity. IAV minigenome reporter assays were performed. Data"/>
 <result pre="p38 MAPK activation Cell signaling manipulated by viruses can support" exact="viral" post="replication [34]. To further elucidate the underlying mechanisms regarding"/>
 <result pre="NF-κB and AKT signaling pathways were activated by influenza A" exact="virus infection." post="Moreover, we observed that the activation of p38 MAPK"/>
 <result pre="transcriptional activity (Fig. 3B). Given that the reduction of the" exact="viral" post="polymerase transcription activity was caused by erucic acid, it"/>
 <result pre="it became necessary to clarify whether the inhibitory effect on" exact="viral" post="polymerase transcription activity was associated with p38 MAPK and"/>
 <result pre="erucic acid caused an additive effect on the inhibition of" exact="viral" post="polymerase transcription activity (Fig. 3C). The above results indicated"/>
 <result pre="for 24 h prior to Western blot analysis. Phosphorylated and" exact="total" post="NF-κB (p65), MAPKs and AKT were detected with specific"/>
 <result pre="p38 MAPK and NF-κB inhibitors, and erucic acid treatment reduced" exact="viral" post="polymerase activity. IAV minigenome-based reporter system-transfected cells were treated"/>
 <result pre="(column 4). 3.4 Erucic acid inhibits IAV-triggered pro-inflammatory mediator production" exact="Increased" post="production of cytokines mediated by aberrant signaling contributes to"/>
 <result pre="release by using Luminex assays. The cytokine profile revealed that" exact="infection" post="with influenza A virus resulted in a significant elevation"/>
 <result pre="A549 cells were incubated with erucic acid for 24 h;" exact="total" post="proteins or culture supernatant were collected for analysis of"/>
 <result pre="mediators, lung damage is worsened by apoptosis induction during influenza" exact="virus infection" post="[38]. In this regard, the effect of erucic acid"/>
 <result pre="lung damage is worsened by apoptosis induction during influenza virus" exact="infection" post="[38]. In this regard, the effect of erucic acid"/>
 <result pre="influenza virus-infected cells (Fig. 5B). It is well established that" exact="viral" post="products such as vRNA, containing a 5′ppp end groups,"/>
 <result pre="released by host cells are vital cytokines in response to" exact="viral infection." post="Previous reports have shown that NF-κB and p38 MAPK"/>
 <result pre="MAPK inhibitor SB203580 (column 6) treatment resulted in suppression of" exact="type I" post="INF (IFN-β) and III INF (IFN-λ1) production. Combined treatment"/>
 <result pre="of type I INF (IFN-β) and III INF (IFN-λ1) production." exact="Combined" post="treatment with the two inhibitors generated synergistic effects (Fig."/>
 <result pre="the immunomodulatory properties of IFNs contribute to deleterious outcomes of" exact="viral infection" post="[44]. To investigate effects of erucic acid on IFN-associated"/>
 <result pre="immunomodulatory properties of IFNs contribute to deleterious outcomes of viral" exact="infection" post="[44]. To investigate effects of erucic acid on IFN-associated"/>
 <result pre="were pre-treated with IFN-β (500 ng/mL) for 4 h prior to IAV" exact="infection" post="in the presence and absence of erucic acid. Pretreatment"/>
 <result pre="for 4 h prior to IAV infection in the presence and" exact="absence of" post="erucic acid. Pretreatment with IFN-β significantly amplified expression of"/>
 <result pre="reporter gene assays to analyze IFN-β signaling in cells with" exact="transient" post="ISRE reporter plasmid transfection were performed. It was observed"/>
 <result pre="gait and labored breathing, and erucic acid-administered mice exhibited relieved" exact="disease" post="symptoms or none (Fig. 7A). Similar results were observed"/>
 <result pre="respectively, vs. 0%). In addition, continuous weight loss caused by" exact="viral infection" post="was reversed by erucic acid treatment (Fig. 7C). Differences"/>
 <result pre="vs. 0%). In addition, continuous weight loss caused by viral" exact="infection" post="was reversed by erucic acid treatment (Fig. 7C). Differences"/>
 <result pre="7F and G). Furthermore, histopathological examination of lung tissues revealed" exact="viral infection" post="triggered massive inflammatory cell infiltration leading to extensive alveolar"/>
 <result pre="and G). Furthermore, histopathological examination of lung tissues revealed viral" exact="infection" post="triggered massive inflammatory cell infiltration leading to extensive alveolar"/>
 <result pre="which was significantly ameliorated by erucic acid treatment (Fig. 7H," exact="upper" post="panel). In addition, immunohistochemical analysis suggested that CD3+ immunocytes"/>
 <result pre="IAV compared with mice receiving erucic acid treatment (Fig. 7H," exact="lower" post="panel). In line with this, virus-mediated CD3+CD8+ cytotoxic T"/>
 <result pre="Erucic acid administration protects against lethal IAV challenge in vivo." exact="Female" post="BALB/c mice received erucic acid (50 and 100 mg/kg/day) for"/>
 <result pre="prior to intranasal inoculation with A/FM1/H1N1 virus (5 LD50). (A)" exact="General" post="appearance of mice with or without erucic acid treatment"/>
 <result pre="error of the mean. ∗∗P &amp;lt; 0.01 vs. IAV-infected. (E)" exact="Total" post="protein concentration determined by BCA assay in BALF at"/>
 <result pre="∗∗∗P &amp;lt; 0.001 vs. IAV-infected. (F–G) On day 7 p.i.," exact="viral" post="titers in lungs were determined by plaque assay and"/>
 <result pre="determined by plaque assay and lung homogenate was analyzed for" exact="viral" post="proteins (PB1, PB2 and M1) by immunoblotting; GAPDH was"/>
 <result pre="into the mechanism of action of erucic acid in IAV" exact="infection" post="in vivo, effects of erucic acid on IAV-mediated signal"/>
 <result pre="the levels of IFNs in vivo. As expected, members of" exact="type I" post="IFNs (IFN-α/β) were reduced by erucic acid treatment (Fig."/>
 <result pre="linked to influenza severity. Fig. 8 Erucic acid attenuates excessive" exact="pulmonary" post="inflammation upon IAV challenge in vivo. (A) On day"/>
 <result pre="outcome of critically ill patients with HPAI H5N1 or H7N9" exact="virus infection" post="due to induction of an uncontrollable cytokine storm [10,45]."/>
 <result pre="of critically ill patients with HPAI H5N1 or H7N9 virus" exact="infection" post="due to induction of an uncontrollable cytokine storm [10,45]."/>
 <result pre="benefits of immunomodulatory agents for influenza treatments. Nevertheless, given that" exact="viral" post="PAMPs are detected by cellular PRRs and subsequently evoke"/>
 <result pre="the presence of PAMPs to be sensed by cellular PRRs." exact="Viral" post="load is a critical contributor in the pathogenesis of"/>
 <result pre="assays (Figs. 2A and B). In addition, virus titers and" exact="viral" post="antigens were decreased in mice treated with erucic acid"/>
 <result pre="that inhibition of NF-κB and p38 kinase signaling pathways inhibited" exact="viral" post="replication [16,23]. Treatment with specific NF-κB or p38 kinase"/>
 <result pre="specific NF-κB or p38 kinase inhibitors blocked nuclear-cytoplasmic translocation of" exact="viral" post="ribonucleoproteins and thereby reduced virus titers [16,20]. Inhibition of"/>
 <result pre="the NF-κB signaling pathway effectively impairs transcriptional activities of the" exact="viral" post="polymerase complex [15]. In this study, data revealed that"/>
 <result pre="in vitro and in vivo (Fig. 3, Fig. 8A). Additionally," exact="viral" post="polymerase transcription activity was reduced further by co-treatment with"/>
 <result pre="by erucic acid resulted in decreased transcriptional activities of the" exact="viral" post="polymerase complex, thereby inhibiting viral replication. Based on these"/>
 <result pre="decreased transcriptional activities of the viral polymerase complex, thereby inhibiting" exact="viral" post="replication. Based on these observations, it is probable that"/>
 <result pre="acid was a result of reducing transcriptional activities of the" exact="viral" post="polymerase complex via inhibition of NF-κB and p38 kinase"/>
 <result pre="NF-κB and p38 kinase signaling. Influenza progresses from an initial" exact="acute" post="lung injury (ALI) or continues progress to form severe"/>
 <result pre="acute lung injury (ALI) or continues progress to form severe" exact="acute respiratory distress syndrome" post="(ARDS), which has been ascribed to the disordered inflammatory"/>
 <result pre="lung injury (ALI) or continues progress to form severe acute" exact="respiratory" post="distress syndrome (ARDS), which has been ascribed to the"/>
 <result pre="(ALI) or continues progress to form severe acute respiratory distress" exact="syndrome" post="(ARDS), which has been ascribed to the disordered inflammatory"/>
 <result pre="are closely correlated with symptoms and fever in human influenza" exact="infection" post="[9,46]. Elevation of IL-17 and IP-10 was reported to"/>
 <result pre="to mediate ALI during the 2009 pandemic influenza A (H1N1)" exact="virus infection" post="[47,48]. Development of ALI or ARDS results from the"/>
 <result pre="mediate ALI during the 2009 pandemic influenza A (H1N1) virus" exact="infection" post="[47,48]. Development of ALI or ARDS results from the"/>
 <result pre="or ARDS results from the disruption of normal functions of" exact="epithelial" post="sodium channels and tight junctions of epithelial-endothelial barriers based"/>
 <result pre="including IL-6, TNF-α, MCP-1, IP-10, IL-17 and RANTES, evoked by" exact="viral infection" post="or viral product stimulation, were reversed by erucic acid"/>
 <result pre="IL-6, TNF-α, MCP-1, IP-10, IL-17 and RANTES, evoked by viral" exact="infection" post="or viral product stimulation, were reversed by erucic acid"/>
 <result pre="MCP-1, IP-10, IL-17 and RANTES, evoked by viral infection or" exact="viral" post="product stimulation, were reversed by erucic acid treatment (Figs."/>
 <result pre="involved in influenza virus-induced dysregulation of pro-inflammatory mediator production. NF-κB" exact="deficiency" post="markedly reduces H5N1-mediated hypercytokinemia [17]. Likewise, pharmacological inhibition of"/>
 <result pre="no difference in the pattern of NF-κB activation in human" exact="primary" post="macrophages with H5N1 and H1N1 virus infection; however, increased"/>
 <result pre="NF-κB activation in human primary macrophages with H5N1 and H1N1" exact="virus infection;" post="however, increased p38 activation mediated by H5N1 was observed"/>
 <result pre="[36,37]. Overexpression of COX-2 is implicated in the pathogenesis of" exact="avian influenza" post="H5N1 infections [54]. Expression of COX-2 is induced upon"/>
 <result pre="COX-2 is implicated in the pathogenesis of avian influenza H5N1" exact="infections" post="[54]. Expression of COX-2 is induced upon viral PAMPs"/>
 <result pre="influenza H5N1 infections [54]. Expression of COX-2 is induced upon" exact="viral" post="PAMPs stimulation [55,56]. Consistently, levels of COX-2 and PEG2"/>
 <result pre="(Figs. 4B and C and Fig. 5G and H). Genetic" exact="deficiency" post="or pharmacological inhibition of COX-2 significantly decreases virus-mediated inflammation"/>
 <result pre="antiviral agents with COX-2 inhibitors protects mice from lethal H5N1" exact="infections" post="[12]. Induction of COX-2-derived PGE2 following IAV infection is"/>
 <result pre="lethal H5N1 infections [12]. Induction of COX-2-derived PGE2 following IAV" exact="infection" post="is not limited to suppressing antiviral innate immune responses"/>
 <result pre="[12]. Induction of COX-2-derived PGE2 following IAV infection is not" exact="limited" post="to suppressing antiviral innate immune responses and adapts immunity,"/>
 <result pre="via inhibition of NF-κB and p38 kinase signaling during influenza" exact="virus infection." post="Erucic acid treatment was also found to decrease the"/>
 <result pre="were firmly established as crucial components of innate immunity against" exact="viral infection." post="Type I and III IFNs with their receptor-triggered activation"/>
 <result pre="established as crucial components of innate immunity against viral infection." exact="Type I" post="and III IFNs with their receptor-triggered activation of tripartite"/>
 <result pre="an ISRE DNA element [60]. IFN-β deficient samples exhibit increased" exact="susceptibility to" post="various types of viral infection, including vaccinia virus [61],"/>
 <result pre="IFN-β deficient samples exhibit increased susceptibility to various types of" exact="viral infection," post="including vaccinia virus [61], coxsackievirus B3 [62], Friend retrovirus"/>
 <result pre="exhibit increased susceptibility to various types of viral infection, including" exact="vaccinia" post="virus [61], coxsackievirus B3 [62], Friend retrovirus [63] and"/>
 <result pre="that IFN-β acts in a disease-promoting role in response to" exact="viral" post="pathogens. Recent evidence suggests that IAV-mediated IFN-β expression in"/>
 <result pre="to lung injury [38]. It was reported that IFN signaling" exact="deficiency" post="attenuates inflammation and protects mice from IAV- or respiratory"/>
 <result pre="signaling deficiency attenuates inflammation and protects mice from IAV- or" exact="respiratory" post="syncytial virus (RSV)-mediated morbidity [44,65]. In line with this,"/>
 <result pre="the IFN-mediated amplification of a detrimental pro-inflammatory response to influenza" exact="virus infection." post="In vitro data suggested that an increasing percentage of"/>
 <result pre="suggested that an increasing percentage of apoptotic cells following influenza" exact="virus infection" post="and vRNA stimulation was decreased upon erucic acid treatment"/>
 <result pre="that an increasing percentage of apoptotic cells following influenza virus" exact="infection" post="and vRNA stimulation was decreased upon erucic acid treatment"/>
 <result pre="as apoptosis marker active caspase-3 in vivo (Fig. 7J). During" exact="viral infection," post="apoptosis of the virus-infected cells was regarded as the"/>
 <result pre="with ARDS exhibited severe lung damage involving apoptosis of alveolar" exact="epithelial" post="and endothelial cells [68,69]. It has been demonstrated that"/>
 <result pre="atmosphere is significantly associated with the rapid development of IAV-mediated" exact="acute" post="lung injury and progression to ARDS [38]. Additionally, CTLs"/>
 <result pre="IAV-infected cells [70,71], which is as an important limitation of" exact="viral" post="replication. However, excessive CD8+ T lymphocytes recruitment contributes to"/>
 <result pre="lymphocytes recruitment contributes to immunopathology in the course of a" exact="viral infection." post="Peripheral blood CD8+ T lymphocytes are more abundant in"/>
 <result pre="CD8+ T lymphocytes are more abundant in patients with severe" exact="pneumonia" post="than moderate pneumonia [72]. Histological findings of the lungs"/>
 <result pre="are more abundant in patients with severe pneumonia than moderate" exact="pneumonia" post="[72]. Histological findings of the lungs of novel swine"/>
 <result pre="increased CD8+ T lymphocyte and granzyme B+ expression correlates with" exact="diffuse" post="alveolar damage and fatal outcome [73]. Recipient HA-transgenic mice"/>
 <result pre="IAV-specific CD8+ T lymphocytes trigger non-specific apoptosis of bystander alveolar" exact="epithelial" post="cells [75]. The current data showed that erucic acid"/>
 <result pre="of influenza virus-infected cells resulted in the significant suppression of" exact="viral" post="propagation and pro-inflammatory mediator production via NF-κB and p38"/>
 <result pre="from influenza virus-induced lung injury and improved mortality by attenuating" exact="viral" post="load, CTL recruitment and excessive pro-inflammatory mediators. Therefore, it"/>
 <result pre="it is suggested that erucic acid exerted inhibitory effects on" exact="viral" post="replication and modulated virus-evoked excess pro-inflammatory responses that may"/>
 <result pre="outcome of human influenza A (H5N1) is associated with high" exact="viral" post="load and hypercytokinemiaNat. Med.1220061203120716964257 11SalomonR.HoffmannE.WebsterR.G.Inhibition of the cytokine response"/>
 <result pre="Natl. Acad. Sci. U.S.A.10520088091809618523003 13SharmaG.Champalal SharmaD.Hwei FenL.Reduction of influenza virus-induced" exact="lung inflammation" post="and mortality in animals treated with a phosophodisestrase-4 inhibitor"/>
 <result pre="activation of p38 mitogen-activated protein kinase is a determinant of" exact="respiratory" post="virus entry and tropismJ. Virol.842010113591137320702616 20NencioniL.De ChiaraG.SgarbantiR.Bcl-2 expression and"/>
 <result pre="with influenza A virus: impact on virally induced apoptosis and" exact="viral" post="replicationJ. Biol. Chem.2842009160041601519336399 21HuiK.P.Y.LeeS.M.Y.CheungC.y.Induction of proinflammatory cytokines in primary"/>
 <result pre="and viral replicationJ. Biol. Chem.2842009160041601519336399 21HuiK.P.Y.LeeS.M.Y.CheungC.y.Induction of proinflammatory cytokines in" exact="primary" post="human macrophages by influenza A virus (H5N1) is selectively"/>
 <result pre="c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial" exact="epithelial" post="cellsJ. Immunol.16420003222322810706714 23BorgelingY.SchmolkeM.ViemannD.Inhibition of p38 mitogen-activated protein kinase impairs"/>
 <result pre="Immunol.16420003222322810706714 23BorgelingY.SchmolkeM.ViemannD.Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced" exact="primary" post="and secondary host gene responses and protects mice from"/>
 <result pre="of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and" exact="secondary" post="host gene responses and protects mice from lethal H5N1"/>
 <result pre="vivoLife Sci.200201811512529555588 26LuoZ.LiuL.F.WangX.H.Epigoitrin, an alkaloid from Isatis indigotica, reduces H1N1" exact="infection" post="in stress-induced susceptible model in vivo and in vitroFront."/>
 <result pre="activity of Isatis indigotica root-derived clemastanin B against human and" exact="avian influenza" post="A and B viruses in vitroInt. J. Mol. Med.31201386787323403777"/>
 <result pre="pro-inflammatory responseJ. Ethnopharmacol.174201537938626320688 30ZhouB.LiJ.LiangX.Transcriptome profiling of influenza A virus-infected lung" exact="epithelial" post="(A549) cells with lariciresinol-4-beta-D-glucopyranoside treatmentPLoS One122017e0173058 31KimE.KoH.J.JeonS.J.The memory-enhancing effect"/>
 <result pre="treatmentPLoS One122017e0173058 31KimE.KoH.J.JeonS.J.The memory-enhancing effect of erucic acid on scopolamine-induced" exact="cognitive impairment" post="in micePharmacol. Biochem. Behav.1422016859026780350 32ReedL.J.MuenchH.A simple method of estimating"/>
 <result pre="Lung Cell Mol. Physiol.2852003L1087109812871860 38HögnerK.WolffT.PleschkaS.Macrophage-expressed IFN-β contributes to apoptotic alveolar" exact="epithelial" post="cell injury in severe influenza virus pneumoniaPLoS Pathog.92013e1003188 39BeschR.PoeckH.HohenauerT.Proapoptotic"/>
 <result pre="Pathog.92013e1003188 39BeschR.PoeckH.HohenauerT.Proapoptotic signaling induced by RIG-I and MDA-5 results in" exact="type I" post="interferon-independent apoptosis in human melanoma cellsJ. Clin. Investig.11920092399241119620789 40RossmanJ.S.LambR.A.Autophagy,"/>
 <result pre="and MDA-5 results in type I interferon-independent apoptosis in human" exact="melanoma" post="cellsJ. Clin. Investig.11920092399241119620789 40RossmanJ.S.LambR.A.Autophagy, apoptosis, and the influenza virus"/>
 <result pre="interacts with heat shock protein Hsp90 in human alveolar basal" exact="epithelial" post="cells: implication for virus-induced apoptosisVirol. J.8201118121501532 42PanneD.ManiatisT.HarrisonS.C.An atomic model"/>
 <result pre="apoptosisVirol. J.8201118121501532 42PanneD.ManiatisT.HarrisonS.C.An atomic model of the interferon-beta enhanceosomeCell12920071111112317574024 43OnoguchiK.YoneyamaM.TakemuraA.Viral" exact="infections" post="activate types I and III interferon genes through a"/>
 <result pre="common mechanismJ. Biol. Chem.28220077576758117204473 44DavidsonS.CrottaS.McCabeT.M.Pathogenic potential of interferon αβ in" exact="acute" post="influenza infectionNat. Commun.52014386424844667 45ChiY.ZhuY.WenT.Cytokine and chemokine levels in patients"/>
 <result pre="45ChiY.ZhuY.WenT.Cytokine and chemokine levels in patients infected with the novel" exact="avian influenza" post="A (H7N9) virus in ChinaJ. Infect. Dis.20820131962196723990573 46KaiserL.FritzR.S.StrausS.E.Symptom pathogenesis"/>
 <result pre="A (H7N9) virus in ChinaJ. Infect. Dis.20820131962196723990573 46KaiserL.FritzR.S.StrausS.E.Symptom pathogenesis during" exact="acute" post="influenza: interleukin-6 and other cytokine responsesJ. Med. Virol.64200126226811424113 47WangW.YangP.ZhongY.Monoclonal"/>
 <result pre="47WangW.YangP.ZhongY.Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced" exact="acute" post="lung injuryCell Res.23201357758023419516 48LiC.YangP.SunY.IL-17 response mediates acute lung injury"/>
 <result pre="(H1N1) virus induced acute lung injuryCell Res.23201357758023419516 48LiC.YangP.SunY.IL-17 response mediates" exact="acute" post="lung injury induced by the 2009 pandemic influenza A"/>
 <result pre="the 2009 pandemic influenza A (H1N1) virusCell Res.22201252853822025253 49MullinJ.M.SnockK.V.Effect of" exact="tumor" post="necrosis factor on epithelial tight junctions and transepithelial permeabilityCancer"/>
 <result pre="A (H1N1) virusCell Res.22201252853822025253 49MullinJ.M.SnockK.V.Effect of tumor necrosis factor on" exact="epithelial" post="tight junctions and transepithelial permeabilityCancer Res.501990217221762180562 50RouxJ.KawakatsuH.GartlandB.Interleukin-1β decreases expression"/>
 <result pre="junctions and transepithelial permeabilityCancer Res.501990217221762180562 50RouxJ.KawakatsuH.GartlandB.Interleukin-1β decreases expression of the" exact="epithelial" post="sodium channel alpha-subunit in alveolar epithelial cells via a"/>
 <result pre="decreases expression of the epithelial sodium channel alpha-subunit in alveolar" exact="epithelial" post="cells via a p38 MAPK-dependent signaling pathwayJ. Biol. Chem.2802005185791858915755725"/>
 <result pre="Immunol.168200283984511777980 52GaliettaL.J.FolliC.MarchettiC.Modification of transepithelial ion transport in human cultured bronchial" exact="epithelial" post="cells by interferon-γAm. J. Physiol. Lung Cell Mol. Physiol.2782000L1186119410835324"/>
 <result pre="Lung Cell Mol. Physiol.2782000L1186119410835324 53LeeD.C.CheungC.Y.LawA.H.p38 mitogen-activated protein kinase-dependent hyperinduction of" exact="tumor" post="necrosis factor alpha expression in response to avian influenza"/>
 <result pre="hyperinduction of tumor necrosis factor alpha expression in response to" exact="avian influenza" post="virus H5N1J. Virol.792005101471015416051807 54LeeS.M.CheungC.Y.NichollsJ.M.Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a"/>
 <result pre="of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of" exact="avian influenza" post="H5N1 infectionJ. Infect. Dis.198200852553518613795 55KirkbyN.S.ZaissA.K.WrightW.R.Differential COX-2 induction by viral"/>
 <result pre="avian influenza H5N1 infectionJ. Infect. Dis.198200852553518613795 55KirkbyN.S.ZaissA.K.WrightW.R.Differential COX-2 induction by" exact="viral" post="and bacterial PAMPs: consequences for cytokine and interferon responses"/>
 <result pre="H5N1 infectionJ. Infect. Dis.198200852553518613795 55KirkbyN.S.ZaissA.K.WrightW.R.Differential COX-2 induction by viral and" exact="bacterial" post="PAMPs: consequences for cytokine and interferon responses and implications"/>
 <result pre="mRNA stabilitySci. Rep.620162727527265729 57CareyM.A.BradburyJ.A.SeubertJ.M.Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2" exact="deficiency" post="on the host response to influenza A viral infectionJ."/>
 <result pre="and COX-2 deficiency on the host response to influenza A" exact="viral" post="infectionJ. Immunol.17520056878688416272346 58CareyM.A.BradburyJ.A.RebollosoY.D.Pharmacologic inhibition of COX-1 and COX-2 in"/>
 <result pre="Immunol.17520056878688416272346 58CareyM.A.BradburyJ.A.RebollosoY.D.Pharmacologic inhibition of COX-1 and COX-2 in influenza A" exact="viral infection" post="in micePLoS One52010e11610 59CoulombeF.JaworskaJ.VerwayM.Targeted prostaglandin E2 inhibition enhances antiviral"/>
 <result pre="58CareyM.A.BradburyJ.A.RebollosoY.D.Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral" exact="infection" post="in micePLoS One52010e11610 59CoulombeF.JaworskaJ.VerwayM.Targeted prostaglandin E2 inhibition enhances antiviral"/>
 <result pre="59CoulombeF.JaworskaJ.VerwayM.Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of" exact="type I" post="interferon and apoptosis in macrophagesImmunity40201455456824726877 60SadlerA.J.WilliamsB.R.Interferon-inducible antiviral effectorsNat. Rev."/>
 <result pre="62DeonarainR.CerulloD.FuseK.Protective role for interferon-beta in coxsackievirus B3 infectionCirculation11020043540354315249500 63GerlachN.SchimmerS.WeissS.Effects of" exact="type I" post="interferons on Friend retrovirus infectionJ. Virol.8020063438344416537611 64KoernerI.KochsG.KalinkeU.Protective role of"/>
 <result pre="signaling amplifies early proinflammatory cytokine production in the lung during" exact="respiratory" post="syncytial virus infectionJ. Virol.8820146128613624648449 66GautierG.HumbertM.DeauvieauF.A type I interferon autocrine-paracrine"/>
 <result pre="in the lung during respiratory syncytial virus infectionJ. Virol.8820146128613624648449 66GautierG.HumbertM.DeauvieauF.A" exact="type I" post="interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70"/>
 <result pre="lung biopsies in patients with swine-origin influenza type A/H1N1 and" exact="acute" post="respiratory failureClinics (Sao Paulo)6520101229123721340209 69UiprasertkulM.KitphatiR.PuthavathanaP.Apoptosis and pathogenesis of avian"/>
 <result pre="biopsies in patients with swine-origin influenza type A/H1N1 and acute" exact="respiratory" post="failureClinics (Sao Paulo)6520101229123721340209 69UiprasertkulM.KitphatiR.PuthavathanaP.Apoptosis and pathogenesis of avian influenza"/>
 <result pre="and acute respiratory failureClinics (Sao Paulo)6520101229123721340209 69UiprasertkulM.KitphatiR.PuthavathanaP.Apoptosis and pathogenesis of" exact="avian influenza" post="A (H5N1) virus in humansEmerg. Infect. Dis.13200770871217553248 70IshikawaE.NakazawaM.YoshinariM.Role of"/>
 <result pre="influenza A (H5N1) virus in humansEmerg. Infect. Dis.13200770871217553248 70IshikawaE.NakazawaM.YoshinariM.Role of" exact="tumor" post="necrosis factor-related apoptosis-inducing ligand in immune response to influenza"/>
 <result pre="tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza" exact="virus infection" post="in miceJ. Virol.7920057658766315919918 71KohlmeierJ.E.CookenhamT.RobertsA.D.Type I interferons regulate cytolytic activity"/>
 <result pre="necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus" exact="infection" post="in miceJ. Virol.7920057658766315919918 71KohlmeierJ.E.CookenhamT.RobertsA.D.Type I interferons regulate cytolytic activity"/>
 <result pre="of memory CD8(+) T cells in the lung airways during" exact="respiratory" post="virus challengeImmunity3320109610520637658 72KimJ.E.BauerS.LaK.S.CD4+/CD8+ T lymphocytes imbalance in children with"/>
 <result pre="Clin. Investig.1021998165316619802879 75van de SandtC.E.BarcenaM.KosterA.J.Human CD8(+) T cells damage noninfected" exact="epithelial" post="cells during influenza virus infection in vitroAm. J. Respir."/>
 <result pre="SandtC.E.BarcenaM.KosterA.J.Human CD8(+) T cells damage noninfected epithelial cells during influenza" exact="virus infection" post="in vitroAm. J. Respir. Cell Mol. Biol.57201753654628613916 Appendix A"/>
 <result pre="CD8(+) T cells damage noninfected epithelial cells during influenza virus" exact="infection" post="in vitroAm. J. Respir. Cell Mol. Biol.57201753654628613916 Appendix A"/>
 <result pre="10.13039/501100001809National Natural Science Foundation of China (Grant no. 81873065), the" exact="Secondary" post="Development Projects of Guangdong Famous and Excellent Traditional Chinese"/>
 <result pre="Secondary Development Projects of Guangdong Famous and Excellent Traditional Chinese" exact="Patent" post="Medicines (Grant no. 20174005), the 10.13039/501100003453Natural Science Foundation of"/>
</results>
